Table 6.

Prognostic factors associated with the odds of experiencing an acute or a late toxicity, adjusted for age, grade, treatment length, stage and histologic type

Odds ratio and 95% confidence interval associated with 5 Gy of:		Acute toxicity			Late toxicity
	N	Odds ratio and 95% confidence interval	p-value	N	Odds ratio and 95% confidence interval	p-value
Rectal dose (average)	95	0.98 (0.95, 1.01)	0.31	84	1.00 (0.96, 1.05)	0.93
Rectal dose (max)	96	1.00 (0.98, 1.02)	0.83	85	1.02 (0.99, 1.05)	0.20
Equivalent dose for tumor effects (Gy) Bladder	89	0.99 (0.70, 1.36)	0.95	81	0.90 (0.55, 1.39)	0.63
Equivalent dose (late effects no DMF) Bladder	88	1.00 (0.80, 1.22)	0.98	80	0.96 (0.70, 1.25)	0.76
Equivalent dose for tumor effects(Gy) Surface	91	1.26 (0.72, 2.31)	0.43	81	1.61 (0.84, 3.61)	0.18
Equivalent dose (late effects no DMF) Surface	91	1.13 (0.85, 1.54)	0.40	81	1.05 (0.77, 1.46)	0.74
Equivalent dose for tumor effects (Gy) 0.5 mm	98	0.28 (0.01, 1.84)	0.45	87	0.97 (0.03, 2.82)	0.97
Equivalent dose (late effects no DMF) 0.5 mm	98	0.52 (0.14, 1.28)	0.29	87	1.02 (0.29, 1.73)	0.97

DMF – dose modifying factor